Roche stands behind its breast cancer pill Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Thu F 23 April, 2026

Discover the latest trends, challenges, and strategies shaping the future of patient experience across 80+ companies. sponsored by Courier Health

presented by This Founder Could­n't Find His Own Clin­i­cal Tri­al. Now He's En­rolling Hun­dreds of Pa­tients for Phar­ma's Biggest Names

news Sanofi defends Garijo appointment, says it is 'fully committed' to immunology •  Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategy Roche says its investigational breast cancer pill could outsell Herceptin

Apr 28 12:30 pm ET Connection ≠ continuity: Rethinking long-term evidence in the age of tokenization sponsored by PicnicHealth Apr 29 12:00 pm ET From genotype to outcomes: Real-world evidence in glomerular diseases sponsored by Natera May 05 11:00 am ET The path to self-driving: Leveraging agentic AI to drive the future of clinical drug development sponsored by Medable May 12 10:30 am ET Rules of engagement: How G3BP2 paves the way to rationalize novel degrons sponsored by Thermo Fisher May 20 11:00 am ET Application of Simple Western to analysis of antibody target affinity and specificity sponsored by Bio-Techne

US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. Hear from top executives and investors on how they’re navigating what’s next. Join us.

in case you missed it 1. Pharma-backed petition calls on FDA to reform release of drug rejection letters 2. BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work 3. AbbVie's North Carolina $1.4B manufacturing site to finish during Trump's term 4. Rigel loses Lilly alliance in pharma industry's latest RIPK exit 5. News Briefing Nektar's $325M offering; Maze stock rises; Merck deal rumors; BMS layoffs 6. Roche’s multiple sclerosis pill delays relapse, but liver toxicity could need monitoring 7. Medicare indefinitely delays pilot plan to cover weight loss drugs 8. European health chief says EU is at 'a critical point' in ensuring new drug access